Exact Mass: 551.2366
Exact Mass Matches: 551.2366
Found 121 metabolites which its exact mass value is equals to given mass value 551.2366
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Akt inhibitor VIII
AKT inhibitor VIII (AKTi-1/2) is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity with IC50s of 58 nM, 210 nM, and 2119 nM, respectively.
Phe Asp Arg Asp
Ala Glu Phe Trp
Ala Glu Trp Phe
Ala Phe Glu Trp
Ala Phe Trp Glu
Ala Trp Glu Phe
Ala Trp Phe Glu
Cys His His Arg
Cys His Arg His
Cys Arg His His
Asp Asp Phe Arg
Asp Asp Arg Phe
Asp Phe Asp Arg
Asp Phe Arg Asp
Asp Arg Asp Phe
Asp Arg Phe Asp
Glu Ala Phe Trp
Glu Ala Trp Phe
Glu Phe Ala Trp
Glu Phe Trp Ala
Glu Trp Ala Phe
Glu Trp Phe Ala
Phe Ala Glu Trp
Phe Ala Trp Glu
Phe Asp Asp Arg
Phe Glu Ala Trp
Phe Glu Trp Ala
Phe Arg Asp Asp
Phe Trp Ala Glu
Phe Trp Glu Ala
His Cys His Arg
His Cys Arg His
His His Cys Arg
His His Met Gln
His His Gln Met
His His Arg Cys
His Met His Gln
His Met Gln His
His Gln His Met
His Gln Met His
His Arg Cys His
His Arg His Cys
Met His His Gln
Met His Gln His
Met Gln His His
Asn Gln Gln Tyr
Asn Gln Tyr Gln
Asn Tyr Gln Gln
Pro Ser Trp Tyr
Pro Ser Tyr Trp
Pro Trp Ser Tyr
Pro Trp Tyr Ser
Pro Tyr Ser Trp
Pro Tyr Trp Ser
Gln His His Met
Gln His Met His
Gln Met His His
Gln Asn Gln Tyr
Gln Asn Tyr Gln
Gln Gln Asn Tyr
Gln Gln Tyr Asn
Gln Tyr Asn Gln
Gln Tyr Gln Asn
Arg Cys His His
Arg Asp Asp Phe
Arg Asp Phe Asp
Arg Phe Asp Asp
Arg His Cys His
Arg His His Cys
Ser Pro Trp Tyr
Ser Pro Tyr Trp
Ser Trp Pro Tyr
Ser Trp Tyr Pro
Ser Tyr Pro Trp
Ser Tyr Trp Pro
Trp Ala Glu Phe
Trp Ala Phe Glu
Trp Glu Ala Phe
Trp Glu Phe Ala
Trp Phe Ala Glu
Trp Phe Glu Ala
Trp Pro Ser Tyr
Trp Pro Tyr Ser
Trp Ser Pro Tyr
Trp Ser Tyr Pro
Trp Tyr Pro Ser
Trp Tyr Ser Pro
Tyr Asn Gln Gln
Tyr Pro Ser Trp
Tyr Pro Trp Ser
Tyr Gln Asn Gln
Tyr Gln Gln Asn
Tyr Ser Pro Trp
Tyr Ser Trp Pro
Tyr Trp Pro Ser
Tyr Trp Ser Pro
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-3,4-dihydro-2H-1,5-benzodioxepin-7-sulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
2-[(2R,9S,12R,13R,15S)-15-[(E)-hex-4-enoyl]-12-[(E)-oct-6-enyl]-4,6,18-trioxo-5,16,17-trioxapentacyclo[7.7.2.01,10.02,13.03,7]octadeca-3(7),10-dien-9-yl]acetate
AKT inhibitor VIII
AKT inhibitor VIII (AKTi-1/2) is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity with IC50s of 58 nM, 210 nM, and 2119 nM, respectively.
N-succinyl-Leu-Tyr-7-amido-4-methylcoumarin
Coumarin carrying a methyl group at C-4 and a succinyl-leucyl-tryrosyl side-chain at C-7.